New MRI technique could spot fake tumor growth in brain cancer patients
NCT ID NCT03347617
First seen Oct 31, 2025 · Last updated May 17, 2026 · Updated 24 times
Summary
This study looked at whether a special MRI using ferumoxytol (an iron-based contrast agent) can tell the difference between true tumor growth and treatment-related inflammation (pseudoprogression) in people with glioblastoma receiving immunotherapy. About 52 adults with newly diagnosed glioblastoma were planned to join. The goal was to improve how doctors measure treatment response, avoiding unnecessary changes in therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
OHSU Knight Cancer Institute
Portland, Oregon, 97239, United States
Conditions
Explore the condition pages connected to this study.